
Y Glipt M 500mg/20mg Tablet ER
Marketer
VHVL Inc
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Y Glipt M 500mg/20mg Tablet ER
Metformin/Linagliptin 500mg/20mg Extended-Release tablets combine two agents to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and retinopathy, potentially lowering cardiovascular event risk (heart attack or stroke). This medication may be used as monotherapy or in conjunction with other antidiabetic treatments. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concomitant medications. Taking it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar management prevents future complications. Continued commitment to your doctor's dietary and exercise plan is crucial for successful diabetes management; lifestyle significantly impacts glycemic control. Common side effects include diarrhea, nausea, vomiting, dyspepsia, and cephalalgia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; recognition and management of hypoglycemia are essential. This medication isn't suitable for all individuals. Prior to initiating treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Drug interactions are possible; provide a complete medication list to your doctor for safety assessment. Alcohol should be minimized due to its hypoglycemic potential. Your physician will monitor renal function and blood glucose levels throughout treatment.
Primary Ingredients of Y Glipt M 500mg/20mg Tablet ER
The provided text is "undefined". Therefore, no rephrasing is possible.
Uses of Y Glipt M 500mg/20mg Tablet ER
Managing type 2 diabetes
Major Benefits of Y Glipt M 500mg/20mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. The Y Glipt M 500mg/20mg Extended-Release tablet should be administered with a meal.
Common Side effects of Y Glipt M 500mg/20mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Y Glipt M 500mg/20mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. Consume Y Glipt M 500mg/20mg Extended-Release tablets with food.
How Y Glipt M 500mg/20mg Tablet ER works:
Extended-release Y Glipt M tablets (500mg/20mg) contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Y Glipt M 500mg/20mg Tablet ER is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Y Glipt M 500mg/20mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Y Glipt M 500mg/20mg tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Y Glipt M 500mg/20mg Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Y Glipt M 500mg/20mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverUNSAFE
Use of Y Glipt M 500mg/20mg Extended-Release tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Y Glipt M 500mg/20mg Tablet ER :
Should you forget to take a Y Glipt M 500mg/20mg Extended-Release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Y Glipt M 500mg/20mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
